Abstract
Graft-versus-host disease (GvHD) after bone-marrow transplantation in dogs is controlled by many different genetic systems. In littermate combinations identical for the major histocompatibility complex (MHC) the number of systems that influence GvHD is related to the number of donor lymphocytes injected. If the number of donor lymphocytes administered is sufficiently low, minor histocompatibility systems do not influence survival after bone-marrow transplantation. With increasing numbers of donor lymphocytes the beneficial influence of MHC matching on GvH incidence and severity disappears and minor histocompatibility antigens, coded for on at least two other autosomal chromosomes as well as possibly the Y chromosome, can cause severe GvHD. In contrast, the X chromosome does not appear to carry a histocompatibility system that is of relevance to GvHD control. The severity and tissue distribution of histological signs of GvHD in recipients of bone-marrow and lymph-node cells from MHC-identical donors are similar to those in recipients of MHC-mismatched bone-marrow cells. Female donors do appear to cause severe GvHD more frequently than males. In contrast to rhesus monkey and human bone-marrow cells, dog bone-marrow cells are negative in PHA tests. This is in accordance with the generally benign course of GvHD in dogs that are treated with bone-marrow cells only from histocompatible littermate donors. The influence of the sex of the bone-marrow donor on GvHD incidence and severity is not reflected in differences between PHA tests with male and female dog lymphocytes. A better predictive test for GvH potential than the PHA test appears to be needed. Alternatives to additional donor selection for the prevention of GvHD in histocompatible recipients appear to be the use of a male donor and the removal of lymphocytes from bone-marrow-cell suspensions prior to transplantation.
Similar content being viewed by others
References
Advisory Committee of the International Bone Marrow Transplant Registry: Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. JAMA 238: 591–600, 1977
Advisory Committee of the International Bone Marrow Transplant Registry: Treatment of 144 patients with severe aplastic anemia using immunosuppression and allogeneic bone marrow transplantation. Transplant Proc. 13: 227, 1981
Bukhart, P. T. and Meeuwiszen, H. J.: Immunocompetent cells in human and primate marrow. Transplantation 16: 372–373, 1973
Claman, H. N.: Bone marrow T cells. I. Response to the T cell mitogens, phytohemagglutinin and Concanavalin A. J. Immunol. 112: 960–964, 1974
Dicke, K. A., Tridente, G., and van Bekkum, D. W.: The selective elimination of immunologically competent cells from bone marrow and lymphocyte cell mixtures. Transplantation 8: 422–428, 1969
Dicke, K. A. and van Bekkum, D. W.: Allogeneic bone marrow transplantation after elimination of immunocompetent cells by means of density gradient centrifugation. Transplant. Proc. 3: 366–370, 1971
Dicke, K. A., Löwenberg, B., and Nieuwerkerk, H. T. M.: Elimination of lymphocytes from human marrow suspensions: gradient versus small marrow aspirates. Transplant. Proc. 7 (suppl. 1): 863–866, 1975
Elkins, W. L. and Palm, J.: Identification of a single strong histocompatibility locus in the rat by normal spleen cell transfer. Ann. N. Y. Acad. Sci. 129: 573–576, 1966
Epstein, R. B., Bryant, J., and Thomas, E. D.: Cytogenetic demonstration of permanent tolerance in adult outbred dogs. Transplantation 5: 267–272, 1967
Ford, C. E.: Traffic of lymphoid cells in the body. In G. E. W. Wolstenhome, and R. Porter (eds.): The Thymus: Experimental and Clinical Studies, pp. 131–152, Little, Brown and Co., Boston, 1966
Halle-Pannenko, O., Pritchard, L. L., Motta, R., and Mathe, G.: Non H-2 antigens can induce high GvH mortality in adult recipients of normal spleen cells. Biomedicine 28: 253–255, 1978
Jaffe, W. P. and Payne, L. N.: The genetic basis for the graft against host reaction between inbred lines of fowls. Differences between the rease heath C and I inbred lines. Immunology 5: 399–406, 1962
Joint Report of the 2nd International Workshop on Canine Immunogenetics. Transplant. Proc. 8: 289–314, 1976
Kolb, H., Sale, G. E., Lerner, K. G., Storb, R., and Thomas, E. D.: Pathology of acute graft-versus-host disease in the dog. Am. J. Pathol. 96: 581–594, 1979
Korngold, R. and Sprent, J.: Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148: 1678–1698, 1978
Nelson, B., Calvo, W., Fliedner, T. M., Herbst, E., Bruch, C., Schnappauf, H. P., and Flad, H. D.: The repopulation of lymph nodes of dogs after 1200 R whole body X-irradiation and intravenous administration of mononclear blood leukocytes. Am. J. Pathol. 84: 259–282, 1976
Meera Khan, P., Los, W. R. T., van der Does, J. A., and Epstein, R. B.: Isoenzyme markers in dog blood cells. Transplantation 15: 624–628, 1973
Rodt, H., Kolb, H. J., Netzel., B., Rieder, I., Janka, G., Belohradsky, B., Haas, R. J., and Thierfelder, S.: GvHD suppression by incubation of bone marrow grafts with anti T-cell globulin: Effect in the canine model and application to clinical bone marrow transplantation. Transplant. Proc. 11: 962–966, 1979
Selden, J. R. and Wachtel, S. S.: H-Y antigen in the dog. Transplantation 24: 289–289, 1977
Simonson, M.: Immunogenetic speculations on human kidney transplants. Transplantation 4: 354–364, 1966
Storb, R., Rudolph, R. H., Kolb, H. J., Graham, T. C., Mickelson, E., Erickson, V., Lerner, K. G., Kolb, H., and Thomas, E. D.: Marrow grafts between DLA matched canine littermates. Transplantation 15: 92–100, 1973
Storb, R., Thomas, E. D., Buckner, C. D., Clift, R. A., Johnson, F. L., Fefer, A., Glucksberg, H., Giblett, E. R., Lerner, K. G., and Neiman, P.: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43: 157–180, 1974
Storb, R., Prentice, P. L., and Thomas, E. D.: Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. J. Clin. Invest. 59: 625–632, 1977
Tartakovsky, B., Sega, S., Shani, A., Hellerstein, S., Weinstein, Y., and Bentwich, Z.: Segregation of human peripheral blood lymphocytes according to their affinity for insolubilized histamine. Principal differences between males and females. Clin. Exp. Immunol. 38: 166–172, 1979
Thomas, E. D., Storb, R., Clift, R., Fefer, A., Johnson, F. L., Neiman, P. E., Lerner, K. G., Glucksburg, H., and Buckner, C. D.: Bone marrow transplantation. New Engl. J. Med. 292: 832–842, 1975
Thomas, E. D., Buckner, C.D., Banaji, M., Clift, R. A.. Fefer, A., Flournoy, N., Goodell, B. W., Hickman, R. O., Lerner, K. G., Neiman, P. E., Jale, G. E., Sanders, J. E., Singer, J., Stevens, M., Storb, R., and Weiden, P. L.: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogenic marrow transplantation. Blood 49: 511–533, 1977
Thomas, E. D., Sanders, J. E., Flournoy, N., Johnson, F. L., Buckner, C. D., Clift, R. A., Fefer, A., Goodell, B. W., Storb, R., and Weiden, P. L.: Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54: 468–476, 1979
Uphoff, D. E. and Law, L. W.: Genetic factors influencing irradiation protection by bone marrow. II. The histocompatibility-2- (h-2) locus. J. Natl. Cancer Inst. 20: 617–622, 1958
van Bekkum, D. W., Balner, H., Dicke, K. A., Berg, F. G., vanden, Prinsen, G. H., and Hollander, C. F.: The effect of pretreatment of allogeneic bone marrow graft recipients with antilymphocyte serum on the acute graft-versus-host reaction in monkeys. Transplantation 13: 400–407 1972
van Bekkum, D. W.: The double barrier in bone marrow transplantation. Semin. Hematol. 11: 325–340, 1974
Vriesendorp, H. M.: Major histocompatibility complex of the dog. Erasmus University Rotterdam, The Netherlands, thesis, 1973
Vriesendorp, H. M., Zurcher, C., Bull, R. W., Los, W. R. T., Meera Khan, P., van den Tweel, J. G., Zweibaum, A., and van Bekkum, D. W.: Take and graft versus host reactions of allogeneic bone marrow in tissue typed dogs. Transplant Proc. 7 (suppl. 1): 849–853, 1975a
Vriesendorp, H. M., Bijnen, A. B., Zurcher, C., and van Bekkum, D. W.: Donor selection and bone marrow transplantation in dogs. In F. Kissmeyer-Nielsen (ed): Histocompatibility Testing, pp 963–971, Munksgaard, Copenhagen, 1975
Vriesendorp, H. M., Grosse Wilde, H., and Dorf, M. E.: The major histocompatibility system of the dog. In D. Götze (ed.): The Major Histocompatibility System in Man and Animals, pp. 129–163, Springer-Verlag, Berlin, Heidelberg, New York, 1977
Vriesendorp, H. M., Bijnen, A. B., van Kessel, A. C. M., Obertop, H., and Westbroek, D. L.: Minor histocompatibility systems in dogs. In S. J. Baum and G. D. Ledney (eds.): Experimental Hematology Today 1978, pp. 109–120, Springer-Verlag, New York-Heidelberg, 1978
Vriesendorp, H. M. and, van Bekkum, D. W.: Bona marrow transplantation in the canine. In M. Shifine and F. D. Wilson (eds.): The Canine as a Biomedical Research Model, pp. 153–202, DOE Technical Information Center, Oak Ridge, 1980
Vriesendorp, H. M.: The relative role of the DLA complex in bone marrow transplantation. In M. B. Zaleski, C. J. Abeyounis, and K. Kano (eds.): Immunobiology of the Major Histocompatibility Complex. p. 214, Karger, Basel, 1981
Vriesendorp, H. M., Wagemaker, G., and van Bekkum, D. W.: Engraftment of allogeneic bone marrow. Transplant. Proc. 13: 643–648, 1981
Wagemaker, G., Vriesendorp, H. M., and van Bekkum, D. W.: Successful bone marrow transplantation across major histocompatibility barriers in rhesus monkeys. Transplant. Proc. 13: 875–880, 1981
Zurcher, C., Kessel, A. C. M. van, and Vriesendorp, H. M.: Graft versus host reactions in dogs after total body irradiation and bone marrow transplantation. p. 278, Annual Report REPGO, Rijswijk, The Netherlands, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vriesendorp, H.M., Klapwijk, W.M., Visser, T.P. et al. Alternatives to donor matching for control of graft-versus-host disease. Immunogenetics 15, 79–94 (1982). https://doi.org/10.1007/BF00375505
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00375505